NCT06839157Active, not recruiting
Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer
An Artificial Intelligence - Assisted Model for Predicting Optimal Timing of Surgery in Advanced Ovarian Cancer: the Combined Study of the SUNNY Trial and the Real World Data
Source: ClinicalTrials.gov · Last updated 25 Feb 2026
Brief summary (registry, in English)
This study integrates data from the randomized controlled SUNNY trial (RCT) and real-world (RWD) data, and employs multimodal data fitting to construct a medical artificial intelligence model to identify the clinical characteristics of patient subgroups suitable for primary debulking surgery (PDS) or interval debulking surgery (IDS), and the cutoff values for selecting different timings of surgery for advanced ovarian cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1025 (estimated)
- First submitted
- 18 Feb 2025
- Start date
- 22 Aug 2016
- Primary completion date
- Jun 2027
- Lead sponsor
- Shanghai Gynecologic Oncology Group
- Diseases
- Ovarian cancer
- NCT number
- NCT06839157
What you commit to
- Study type: Observational
- Planned participants: 1025
- From 22 Aug 2016 to the primary completion date, Jun 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Non-epithelial ovarian cancer or borderline tumors.
- Mucinous ovarian cancer.
Other
- Low-grade tumors.
- Missing data on first-line treatment and follow-up
Who the study is looking for
- Age ≥ 18 years
- Patients who were included in the SUNNY study or who were newly diagnosed with stage IIIC or IV primary epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer during the SUNNY study period (2015-2023)
- Underwent primary debulking surgery or interval debulking surgery
- Data avaliable on first-line treatment and follow-up
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.